Juan Carlos
Rodriguez-Manzaneque
![Foto de Juan Carlos](/img/nophoto.png)
![Foto de David Geffen School of Medicine at UCLA](/img/noimage_org.png)
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von David Geffen School of Medicine at UCLA (7)
2014
-
Carboxyl-modified single-wall carbon nanotubes improve bone tissue formation in vitro and repair in an in vivo rat model
International journal of nanomedicine, Vol. 9, pp. 4277-4291
2005
-
Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1
Journal of Biological Chemistry, Vol. 280, Núm. 41, pp. 34796-34804
2001
-
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Núm. 22, pp. 12485-12490
2000
-
Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms
Journal of Biological Chemistry, Vol. 275, Núm. 43, pp. 33471-33479
-
Endothelial cell dysfunction following prolonged activation of progesterone receptor
Human Reproduction, Vol. 15, pp. 39-47
1999
-
Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors
Microcirculation, Vol. 6, Núm. 2, pp. 127-140
-
Progesterone regulates proliferation of endothelial cells
Journal of Biological Chemistry, Vol. 274, Núm. 4, pp. 2185-2192